These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 2453096

  • 1. Epitope analysis of human cytomegalovirus glycoprotein complexes using murine monoclonal antibodies.
    Lussenhop NO, Goertz R, Wabuke-Bunoti M, Gehrz R, Kari B.
    Virology; 1988 Jun; 164(2):362-72. PubMed ID: 2453096
    [Abstract] [Full Text] [Related]

  • 2. Antibodies against neutralization epitopes of human cytomegalovirus gH/gL/pUL128-130-131 complex and virus spreading may correlate with virus control in vivo.
    Lilleri D, Kabanova A, Lanzavecchia A, Gerna G.
    J Clin Immunol; 2012 Dec; 32(6):1324-31. PubMed ID: 22836657
    [Abstract] [Full Text] [Related]

  • 3. Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies.
    Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA.
    J Virol; 1993 Feb; 67(2):703-10. PubMed ID: 7678304
    [Abstract] [Full Text] [Related]

  • 4. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes.
    Kari B, Lussenhop N, Goertz R, Wabuke-Bunoti M, Radeke R, Gehrz R.
    J Virol; 1986 Nov; 60(2):345-52. PubMed ID: 3021969
    [Abstract] [Full Text] [Related]

  • 5. The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific.
    Urban M, Britt W, Mach M.
    J Virol; 1992 Mar; 66(3):1303-11. PubMed ID: 1371164
    [Abstract] [Full Text] [Related]

  • 6. Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.
    Utz U, Britt W, Vugler L, Mach M.
    J Virol; 1989 May; 63(5):1995-2001. PubMed ID: 2467992
    [Abstract] [Full Text] [Related]

  • 7. Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization.
    Speckner A, Glykofrydes D, Ohlin M, Mach M.
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2183-2191. PubMed ID: 10466818
    [Abstract] [Full Text] [Related]

  • 8. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
    Schoppel K, Hassfurther E, Britt W, Ohlin M, Borrebaeck CA, Mach M.
    Virology; 1996 Feb 01; 216(1):133-45. PubMed ID: 8614980
    [Abstract] [Full Text] [Related]

  • 9. Neutralizing monoclonal antibodies that distinguish three antigenic sites on human cytomegalovirus glycoprotein H have conformationally distinct binding sites.
    Simpson JA, Chow JC, Baker J, Avdalovic N, Yuan S, Au D, Co MS, Vasquez M, Britt WJ, Coelingh KL.
    J Virol; 1993 Jan 01; 67(1):489-96. PubMed ID: 7677958
    [Abstract] [Full Text] [Related]

  • 10. Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2.
    Keck ZY, Li TK, Xia J, Bartosch B, Cosset FL, Dubuisson J, Foung SK.
    J Virol; 2005 Nov 01; 79(21):13199-208. PubMed ID: 16227243
    [Abstract] [Full Text] [Related]

  • 11. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.
    Burkhart MD, Kayman SC, He Y, Pinter A.
    J Virol; 2003 Apr 01; 77(7):3993-4003. PubMed ID: 12634359
    [Abstract] [Full Text] [Related]

  • 12. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition.
    Heinz FX, Berger R, Tuma W, Kunz C.
    Virology; 1983 Oct 30; 130(2):485-501. PubMed ID: 6196909
    [Abstract] [Full Text] [Related]

  • 13. Analysis of human antibody responses to human cytomegalovirus envelope glycoproteins found in two families of disulfide linked glycoprotein complexes designated gC-I and gC-II.
    Kari B, Gehrz R.
    Arch Virol; 1990 Oct 30; 114(3-4):213-28. PubMed ID: 2173525
    [Abstract] [Full Text] [Related]

  • 14. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
    Chambers MT, Schwarz MC, Sourisseau M, Gray ES, Evans MJ.
    J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29976678
    [Abstract] [Full Text] [Related]

  • 15. Formalin inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection.
    Harty JT, Plagemann PG.
    J Virol; 1988 Sep 15; 62(9):3210-6. PubMed ID: 2457113
    [Abstract] [Full Text] [Related]

  • 16. A human cytomegalovirus-neutralizing monoclonal antibody recognizes a normal cell protein.
    Michelson S, Tardy-Panit M, Colimon R, Landini MP.
    J Gen Virol; 1989 Mar 15; 70 ( Pt 3)():673-84. PubMed ID: 2471796
    [Abstract] [Full Text] [Related]

  • 17. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
    Cole KS, Alvarez M, Elliott DH, Lam H, Martin E, Chau T, Micken K, Rowles JL, Clements JE, Murphey-Corb M, Montelaro RC, Robinson JE.
    Virology; 2001 Nov 10; 290(1):59-73. PubMed ID: 11883006
    [Abstract] [Full Text] [Related]

  • 18. Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus.
    Lantto J, Fletcher JM, Ohlin M.
    Virology; 2003 Jan 05; 305(1):201-9. PubMed ID: 12504553
    [Abstract] [Full Text] [Related]

  • 19. Cell Attachment Domains of the Porcine Epidemic Diarrhea Virus Spike Protein Are Key Targets of Neutralizing Antibodies.
    Li C, Li W, Lucio de Esesarte E, Guo H, van den Elzen P, Aarts E, van den Born E, Rottier PJM, Bosch BJ.
    J Virol; 2017 Jun 15; 91(12):. PubMed ID: 28381581
    [Abstract] [Full Text] [Related]

  • 20. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F, Hugnot JP, Falconar A, Gentry MK, Morens DM, Murray JM, Schlesinger JJ, Wright PJ, Young P, Van Regenmortel MH.
    Virology; 1992 Apr 15; 187(2):480-91. PubMed ID: 1372140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.